Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 19 Nov 2025 for Amneal Pharmaceuticals, Inc., €505k. Read the official filing
Filing timeline
BuySaleTed C. Nark
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Ted C. Nark: trading record in brief
Ted C. Nark, listed as board member, appears in our data through filings on Amneal Pharmaceuticals, Inc. shares, published by SEC (Form 4). We count 6 filings; the first trade dates from 6 May 2021 and the latest from 17 November 2025.
The open-market record consists of 1 sale worth €505k, with no purchase. Other entries cover 5 option exercises. So far in 2025, the count stands at no purchases and 1 sale.
The record was last updated on 19 November 2025 with an open-market sale (€505k) in Amneal Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Ted C. Nark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
50,000 shares@ US$11.72100.0% of flowClass A Common StockSEC:0001628280-25-053188:0
40,258 sharesClass A Common StockSEC:0001628280-25-023993:0
76,453 sharesClass A Common StockSEC:0001628280-24-023246:0
80,128 sharesClass A Common StockSEC:0001209191-23-028731:0
35,406 sharesClass A Common StockSEC:0001209191-22-028159:0
46,218 sharesClass A Common StockSEC:0001209191-21-030812:0
6 of 6 declarations
